Macroaxis: Personalized Investing
Simple Personalized Investing

SP 500   1,669   2.87  Index Moved Up 0.17%
RHC SHL PRY GXL Corporate Bonds Recent Drops Basic Utilities Software 
United States GSPC USD ...  |  Investing Themes


Processing
Collecting data for VGH

Vision quote and profile

 
 Companies |  Insiders  | Dashboard  
     
0.12
  
STOCK
0.00  No Change   0.00%  
May 22 2013 

Diversification Suggestion

Use Vision to protect against small markets fluctuations. The stock experiences normal downward trend, but the immediate impact on correlations cannot be determined at the moment
Check current 30 days Vision correlation with market (S&P 500)
1 Month Beta 0.0  
Unless we do not have data at the moment the returns on S&P 500 and Vision are completely uncorrelated
Vision Eye Institute Limited not significant BetaVision Eye Institute Beta Legend
VGH Australia Australian #AU000000VGH1AU
Vision Eye Institute Limited
Healthcare
Hospitals
Benchmark S&P 500
http://www.visioneyeinstitute.com.au
Contact Number: 61 3 8844 4000
Currency: AUD - Australian Dollar
Traded on Australian Securities Exchange
    
Shares Outstanding87.4 M
Revenue109.43 M
Gross Profit39 M
EBITDA26.36 M
 United States SP 500   0.17 % Macroaxis: 0.17 Moved Up  
 
 thisGreen VGH VGH.AX agains markets  0.00 % No Change  
 Australia All Or   0.27 % Macroaxis: 0.27 Moved Down  
 
Compare to Competition Get Alpha   Get Advice

Vision Leadership

CA BBus CEO, Managing Director and Director
Assoc BBus CEO, Managing Director and Director
ACIS, FCPA Non Executive Chairman, Chairman of Nomination and Governance Committee, Chairman of Remuneration Committee and Member of Audit and Risk Management Committee

Vision Summary

Vision Eye Institute Limited [VGH] is traded on Australian Securities Exchange in Australia. It is located in Melbourne, VIC and employs 381 people. The company currently falls under 'Micro-Cap' category with current market capitalization of 10.49 M. Vision Eye Institute Limited operates under Healthcare sector and is part of Hospitals industry. This company has 87.4 M outstanding shares.
Vision Eye Institute Limited, together with its subsidiaries, offer private ophthalmic services in Australia. more
Follow Vision with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add Vision to your reader
 

Vision Research Report

Vision vs. Ramsay

Correlation analysis and fundamentals comparison between Vision Eye Institute and Ramsay Health Care L

Vision Directors

FRANZCO MBBS Executive Director
DO MBBS Executive Director
FRANZCO, MBBS Medical Director and Director

Vision Fundamentals

Revenue vs Earnings Per Share
Return On Asset vs Cash Flow from Operations
Revenue vs Price to Sales
One Year Low vs Cash Flow from Operations

 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium